
Archiv der Pharmazie p. 383 - 386 (1997)
Update date:2022-09-26
Topics:
Catarzi, Daniela
Colotta, Vittoria
Varano, Flavia
Cecchi, Lucia
Filacchioni, Guido
Galli, Alessandro
Costagli, Chiara
Some pyrazolo[3,4-c]quinoline-4-ones 1-14 and pyrazolo[3,4-c]-quinoline-1,4-diones 15-17 were prepared and biologically evaluated for their binding at the benzodiazepine receptor (BZR) in rat cortical membranes. The moderate binding activity of 1-5, 7, 9-10, 13 is attributable to the lack of the optional proton acceptor at position-1, while the inactivity of the 1,4-dione derivatives 15-17 is due to the lack of the essential proton acceptor at position-3. These conclusions confirm the validity of our proposed pharmacophoric model.
View MoreChengdu Aslee Biopharmaceuticals, Inc
Contact:18608018419
Address:Chengdu Aslee Biopharmaceuticals, Inc
RongCheng K&S Chemical Co.,Ltd
Contact:0631-7336369
Address:rongcheng ,shandong province china
Contact:86-25-51817806
Address:No. 216, middle longpan road, jincheng tower, floor 21-22, nanjing ,china
Wuxi Morality Chemical Co., Ltd(expird)
Contact:
Address:B/7F, 321th WuYun Rd, Wanda Plaza, Wuxi City, 214174, China
Suzhou Health Chemicals Co., Ltd.
website:http://www.healthchems.com
Contact:13776257979
Address:No. 338, Jingang Avenue,
Doi:10.1039/jr9530003435
(1953)Doi:10.1107/S0567740882002532
(1982)Doi:10.1039/c19680001319
(1968)Doi:10.1016/j.tetasy.2004.11.069
(2005)Doi:10.1039/a802430h
(1998)Doi:10.1080/07328319808003475
(1998)